Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients?

Anti-tumor necrosis factor (TNF) therapy is used for the induction and maintenance of remission in Crohn’s disease (CD) patients. However, primary nonresponders to initial treatment constitute 20%–40% of cases. The causes of this phenomenon are still unknown. In this study, we aimed to determine the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Walczak, Michal, Lykowska-Szuber, Liliana, Plucinska, Marianna, Stawczyk-Eder, Kamila, Zakerska-Banaszak, Oliwia, Eder, Piotr, Krela-Kazmierczak, Iwona, Michalak, Michal, Zywicki, Marek, Karlowski, Wojciech M., Szalata, Marlena, Dobrowolska, Agnieszka, Slomski, Ryszard, Skrzypczak-Zielinska, Marzena
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7456829/
https://ncbi.nlm.nih.gov/pubmed/32922288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01207
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados